首页> 外文OA文献 >Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers

【2h】

Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers

机译：强CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Meera Tugnait; Neeraj Gupta; Michael J. Hanley; Daryl Sonnichsen; David Kerstein; David J. Dorer; Karthik Venkatakrishnan; Narayana Narasimhan;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers [J] . Tugnait Meera, Gupta Neeraj, Hanley Michael J., Clinical pharmacology in drug development . 2020,第2期

机译：强CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响
2. Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers [J] . Progress in Artificial Intelligence . 2020,第2期

机译：强大CYP2C8或CYP3A抑制和CYP3A诱导对Brigatinib的药代动力学，口腔血管性淋巴瘤激酶抑制剂，健康志愿者的影响
3. Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis [J] . Gupta Neeraj, Hanley Michael J., Venkatakrishnan Karthik, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2018,第2期

机译：强CYP3A抑制和诱导对Ixazomib的药代动力学的影响，口服蛋白酶体抑制剂：晚期实体肿瘤或淋巴瘤患者药物 - 药物相互作用研究的结果和生理基础的药代动力学分析
4. Pharmacokinetic Study of Rizatriptan Orally Dissolving Film (ODF) Formulations in Healthy Volunteers [C] . Z.Wang. O. Chu, G. Lu, P. Lai, Annual meeting exposition of the Controlled Release Society . 2011

机译：利扎曲普坦口服溶解膜（ODF）制剂在健康志愿者中的药代动力学研究
5. Propafenone pharmacokinetics: GLC-ECD analysis; metabolic induction by phenobarbital in nonsmoking and smoking healthy volunteers; protein binding; pharmacodynamics in patients [D] . Chan, Grace Lap-Yu 1989

机译：普罗帕酮药代动力学：GLC-ECD分析；非吸烟和吸烟健康志愿者的苯巴比妥诱导代谢；蛋白质结合；患者的药效学
6. Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis [O] . Neeraj Gupta, Michael J. Hanley, Karthik Venkatakrishnan, -1

机译：CYP3A的强抑制和诱导作用对口服蛋白酶体抑制剂Ixazomib的药代动力学的影响：晚期实体瘤或淋巴瘤患者的药物相互作用研究结果以及基于生理的药代动力学分析
7. Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers [O] . Abel, Samantha, Jenkins, Timothy M, Whitlock, Lyndsey A, 2008

机译：CYP3A4诱导剂与无CYP3A4抑制剂对maraviroc在健康志愿者体内药代动力学的影响

Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers

著录项

引文网络

相似文献

相关主题

期刊订阅